AgeX Therapeutics, Inc. (AGE)

R&D to Revenue

0.00%

Fiscal year · Period ending:

AGE logo

AGE R&D to Revenue

Latest reported0.00%
AGE FY R&D/Revenue (472.51% → 0.00%)
High-resolution chart · PNG

AGE r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
13,357.1429%
75.7374%
314.617%
109.6353%
6,633.3333%
309.375%
383.4527%
375.1425%
472.509%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.